Announces $10 Million Share Repurchase Program and Corporate Name Change

Aspire Biopharma Holdings, Inc. has changed its name to Aspire-Lakewood Holdings, Inc. and its Board of Directors has authorized a new $10 million common stock repurchase program. The company stated the repurchase program is supported by the strong financial performance of its recently acquired subsidiary, Dura Control Systems Corp. (DCSC).

Key Details

• Share Repurchase Program: The Board authorized a $10 million stock buyback, effective September 9, 2026, citing a belief that the company's share price is undervalued.
• Corporate Name Change: The company filed a Certificate of Amendment to change its name to Aspire-Lakewood Holdings, Inc., effective September 8, 2026. The Nasdaq ticker symbol will remain "ASBP".
• Acquisition Performance: The company highlighted the financial strength of DCSC, which generated ~$209.5M in revenue and ~$22.3M in Adjusted EBITDA for the full year 2025.